Disease/Infection News

RSS

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

A recent study characterized the SARS-CoV-2 lineages circulating in Papua New Guinea during the second wave of COVID-19.

15 Apr 2022

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Researchers investigated the longevity and intensity of the SARS-CoV-2 vaccine immune response in patients suffering from immune-mediated inflammatory diseases.

15 Apr 2022

How the test-to-treat pillar of the US covid strategy is failing patients

The federal "test-to-treat" program, announced in March, is meant to reduce covid hospitalizations and deaths by quickly getting antiviral pills to people who test positive. But even as cases rise again, many Americans don't have access to the program.

15 Apr 2022

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

A new study examined the serological immune responses and antibody-dependent cell-mediated phagocytosis in individuals who had either received two doses of a standard vaccine regime, a booster dose following the regime, or a breakthrough infection following vaccination.

15 Apr 2022

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

...

15 Apr 2022

Researchers track COVID-fighting antibodies after vaccination

The antibodies generated by Pfizer's COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.

15 Apr 2022

Effects of COVID-19 treatment best with combination therapy

There is a steadily growing arsenal of drugs for COVID-19. Researchers from Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and Freie Universität (FU) Berlin have studied the mechanisms of action of antiviral and anti-inflammatory drugs.

15 Apr 2022

New short-course treatment effective against HIV-associated cryptococcal meningitis

A new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and has the potential to reduce the length and cost of hospital admissions, a study shows.

15 Apr 2022

Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

A booster dose of mRNA vaccine significantly decreases the risk of being infected with either the delta or omicron COVID-19 variants, according to scientists at the Rocky Mountain Center for Occupational and Environmental Health (RMCOEH), a program partnership between the University of Utah and Weber State University.

14 Apr 2022

Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

A new study evaluated the cross-neutralizing potency of serum samples collected from individuals who have been infected with the omicron variant of SARS-CoV-2.

14 Apr 2022

CDC report shows a continual surge in sexually transmitted diseases in US in 2020

The CDC reported a rise in sexually transmitted diseases (STDs) in the United States (US) during 2020, the first year of the COVID-19 pandemic.

14 Apr 2022

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Researchers assessed the protective efficacy of the temperature-stable orally delivered vaccines against respiratory viral pathogens.

14 Apr 2022

Exploring strategies for successful delivery of messenger RNA therapeutics

Researchers reviewed the material properties and administration routes that could successfully deliver a messenger ribonucleic acid therapeutic agent to its targeted site.

14 Apr 2022

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

A new study investigated whether APOBEC proteins can directly edit the RNA sequence of SARS-CoV-2 to generate C-to-U mutations.

14 Apr 2022

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

A recent report suggested that a single dose of the human papillomavirus (HPV) vaccination confers equivalent immunity to a two-dose schedule against cervical cancers caused by HPV.

14 Apr 2022

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

In a recent study, researchers assessed the anti-COVID-19 efficacy of Salvia miltiorrhiza Bunge.

14 Apr 2022

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

Researchers investigated the potential of therapeutic drugs, remdesivir and dexamethasone, when used alone or in combination on neurological complications that arise in COVID-19 affected individuals.

14 Apr 2022

Disease/Infection News

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

How the test-to-treat pillar of the US covid strategy is failing patients

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

Researchers track COVID-fighting antibodies after vaccination

Effects of COVID-19 treatment best with combination therapy

New short-course treatment effective against HIV-associated cryptococcal meningitis

Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

CDC report shows a continual surge in sexually transmitted diseases in US in 2020

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Exploring strategies for successful delivery of messenger RNA therapeutics

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

Study reveals natural infection of pangolins with human RSV

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism

Dietary influences on long COVID in children

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News